Polaryx Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage ...
Brown University cuts stake in Blue Owl private credit fund by over 50% Brown University's $8 billion endowment cut its stake in a publicly traded private credit fund run by alternative asset manager ...
Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, ...
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results